Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease
Zhipei Sang, Keren Wang, Pengfei Zhang, et al.
European Journal of Medicinal Chemistry (2019) Vol. 180, pp. 238-252
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review
Shoaib Manzoor, Nasimul Hoda
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112787-112787
Closed Access | Times Cited: 178
Anticancer Activity of Natural and Synthetic Chalcones
Teodora Constantinescu, Claudiu N. Lungu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11306-11306
Open Access | Times Cited: 114
Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress
Zhipei Sang, Keren Wang, Jianghong Dong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114464-114464
Closed Access | Times Cited: 80
The cellular model for Alzheimer's disease research: PC12 cells
Danni Xie, Ting Deng, Zhenwei Zhai, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 15
Open Access | Times Cited: 43
Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations
Samuele Maramai, Mohamed Benchekroun, Moustafa T. Gabr, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-27
Open Access | Times Cited: 88
Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
Paolo Guglielmi, Bijo Mathew, Daniela Secci, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112650-112650
Closed Access | Times Cited: 69
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 43
A New, Extremely Sensitive, Turn-Off Optical Sensor Utilizing Schiff Base for Fast Detection of Cu(II)
Lotfi M. Aroua, Reham Ali, Abuzar E. A. E. Albadri, et al.
Biosensors (2023) Vol. 13, Iss. 3, pp. 359-359
Open Access | Times Cited: 24
One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor
Mohamed A. Salem, Ahmed Ragab, Ahmed Askar, et al.
European Journal of Medicinal Chemistry (2019) Vol. 188, pp. 111977-111977
Closed Access | Times Cited: 72
The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer’s disease
Akash Verma, Digambar Kumar Waiker, Bhagwati Bhardwaj, et al.
Bioorganic Chemistry (2021) Vol. 119, pp. 105562-105562
Closed Access | Times Cited: 45
Design, synthesis and evaluation of quinoline- O -carbamate derivatives as multifunctional agents for the treatment of Alzheimer’s disease
Hongsong Chen, Jing Mi, Sen Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 19
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
Da-Jiang Zou, Renzheng Liu, Yangjing Lv, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
Development of the “hidden” multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease
Rui Chen, Xinjuan Li, Hongsong Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115253-115253
Closed Access | Times Cited: 16
Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD
Yuting Li, Qiyao Zhang, Xinxin Wang, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108245-108245
Closed Access
Artificial intelligence-driven development of natural multi-target derivatives with BuChE inhibitory activity for treating Alzheimer's disease
Qiyao Zhang, Yuting Li, Qunhua Jin, et al.
Chinese Chemical Letters (2025), pp. 110964-110964
Closed Access
Antioxidants in Anti-Alzheimer's Disease Drug Discovery
Jianan Guo, Yalan Zhu, Jia Zhi, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102707-102707
Closed Access
Synthesis of novel organohalogen chalcone derivatives and screening of their molecular docking study and some enzymes inhibition effects
Serdar Burmaoğlu, Elif Akın Kazancıoğlu, Rüya Kaya, et al.
Journal of Molecular Structure (2020) Vol. 1208, pp. 127868-127868
Closed Access | Times Cited: 48
1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease
Tomasz Wichur, Anna Wiȩckowska, Krzysztof Więckowski, et al.
European Journal of Medicinal Chemistry (2019) Vol. 187, pp. 111916-111916
Closed Access | Times Cited: 47
Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B
Jong‐Min Oh, Hyun‐Jae Jang, Won Jun Kim, et al.
International Journal of Biological Macromolecules (2020) Vol. 151, pp. 441-448
Closed Access | Times Cited: 43
Halogenated Coumarin–Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
Nisha Abdul Rehuman, Jong‐Min Oh, Lekshmi R. Nath, et al.
ACS Omega (2021) Vol. 6, Iss. 42, pp. 28182-28193
Open Access | Times Cited: 37
Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer’s disease
Zhipei Sang, Qing Song, Zhongcheng Cao, et al.
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113310-113310
Closed Access | Times Cited: 32
An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects
Pratibha Sharma, Manjinder Singh
Life Sciences (2023) Vol. 320, pp. 121568-121568
Closed Access | Times Cited: 14
Dual-Target Inhibitors Based on Acetylcholinesterase: Novel Agents for Alzheimer's Disease
Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116810-116810
Closed Access | Times Cited: 4
Synthesis and neuroprotective effects of novel chalcone-triazole hybrids
Pichjira Sooknual, Ratchanok Pingaew, Kamonrat Phopin, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104384-104384
Closed Access | Times Cited: 36
Biological Role of Chalcones in Medicinal Chemistry
Sunil U. Tekale, Samson S. Mashele, Ofentse Jacob Pooe, et al.
IntechOpen eBooks (2020)
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top